Economic Evaluation of Exemestane Versus Tamoxifen in Post-Menopausal Women with Early Breast Cancer from The Egyptian Health Care System Perspective

OBJECTIVES: Breast cancer is the most common cause of cancer death in women worldwide. It imposes a substantial economic burden on the healthcare resources in Egypt each year. It is therefore becoming increasingly important to evaluate the cost-effectiveness of Exemestane 25mg versus Tamoxifen 20mgi...

Full description

Saved in:

Bibliographic Details
Published in:	Value in health Vol. 20; no. 9; p. A440
Main Authors:	Elshafei, zA, Abourawash, AS
Format:	Journal Article
Language:	English
Published:	Lawrenceville Elsevier Science Ltd 01-10-2017
Subjects:	Breast cancer Cancer therapies Clinical medicine Clinical trials Cost analysis Death & dying Economics Health care expenditures Hospitals Medical treatment Menopausal women Metastases Metastasis Pharmacology Postmenopausal women Quality adjusted life years Recurrence Sensitivity analysis Tamoxifen Egypt
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!